The price display of drugs and medical servi­ces will help mitigate spiralling medical insurance and medical costs, says the ...

Trump continues to denigrate and distort American achievements in the service of his whacky devotion to destructive tariffs.

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

With expertise in pharmaceutical supply chains and medical technology, healthcare CEO and entrepreneur Dr. Jay Bhaumik has ...

Commentary: New York must take on Big Pharma by demanding more transparency in pricing and ensuring generics aren't delayed ...

Tariffs will trigger some job losses, and impact future investment, but Ireland’s strategic value remains solid - ‘Pharma isn ...

For small business owners like me, increasing costs threaten the well-being of our staff and the financial stability of our ...

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...

While Lilly's success with GLP-1 drugs is certainly impressive, I have my eyes on another area of the company this year.

Traditionally, stock market corrections have been the perfect time for long-term-minded investors with ample cash on hand to ...

Americans pay far more for GLP-1 drugs than citizens in other wealthy nations. If Dr. Marty Makary, the new FDA commissioner, ...